Study Finds JAK Inhibitors Do Not Increase Risks of Serious Adverse Events in Patients with Atopic Dermatitis
MedEsthetics
FEBRUARY 12, 2024
The study from Pusan National University revealed that JAK inhibitor use is not associated with a greater risk of serious adverse events like malignancy, thromboembolism or major adverse cardiac events.
Let's personalize your content